| Literature DB >> 19699558 |
Abstract
BACKGROUND: Hospital emergency management plans are essential and must include input from an infection preventionist (IP). Multiple hospital planning documents exist, but many do not address infection prevention issues, combine them with noninfection prevention issues, or are disease/event specific. An all-encompassing emergency management planning guide for IPs is needed.Entities:
Mesh:
Year: 2009 PMID: 19699558 PMCID: PMC7132688 DOI: 10.1016/j.ajic.2009.04.286
Source DB: PubMed Journal: Am J Infect Control ISSN: 0196-6553 Impact factor: 2.918
Infection prevention components of a hospital emergency management plan
| Hospital emergency management plan and biological annex |
| • Addresses all biologic events, including bioterrorism, emerging infectious diseases, and pandemic influenza |
| • Identifies contact names and numbers for local and state health department, state health association, and tribal health association |
| • Is coordinated with local, state, and federal emergency management plans |
| • Identifies the person(s) authorized to implement/activate the biologic annex plan and the organizational structure that will be used, including the delegation of authority to carry out the plan 24/7 |
| • Describes the responsibilities of key personnel and departments (and back-ups for key personnel) within the facility related to executing the biologic annex component of the Plan |
| • Defines how biologic events are different from other types of MCEs |
| • Has planning committee focusing on biologic events that includes an infection preventionist and/or hospital epidemiologist |
| • Stratifies implementation of specific actions on the basis of the WHO pandemic phases, US government pandemic stages, and the pandemic severity index level worldwide, in the United States, and at the local level |
| • Stratifies implementation of specific actions for a bioterrorism attack on the basis of whether the attack is overt or covert and on the basis of high-risk syndromes or suspected routes of disease transmission |
| • Describes the epidemiologic signs of a potential bioterrorism attack |
| • States how often the annex will be updated and by whom, including contact names/information, incorporating lessons learned from exercises/drills, and changes in recommendations related to managing biologic events |
| Assessing hospital readiness for MCE |
| • States how and when a facility assessment will be performed that addresses infection prevention issues, such as location and amounts of hand hygiene products, isolation rooms/areas, and others |
| • Incorporates biologic scenarios, such as pandemic influenza or bioterrorism, into a disaster exercise; whenever possible, this exercise should be community wide |
| Infection prevention polices and procedures |
| • Has a protocol for providing 24/7 infection prevention and control coverage, including coverage for outpatient facilities or alternate care sites owned/operated by the hospital |
| • Has a protocol for authorizing the hospital epidemiologist or Infection Control Committee or its designee to rapidly implement prevention and control measures in response to a biologic event |
| • Has a protocol for personal protective equipment (PPE) use and hand hygiene |
| • Has a policy for physically isolating and managing contaminated vehicles |
| • Has a procedure related to more frequent checking of patients' oxygenation and early transfer to an intensive care unit to reduce the risk of infection transmission by allowing for elective, early intubation to be done in a controlled environment by minimal staff |
| • Includes policies for modifying admission criteria on the basis of current bed capacity and disease status, including procedures for closing the facility to potentially infectious patients or noninfectious patients |
| • Has a protocol for limiting or restricting visitors to the facility during a biologic event, including coordination with security or local law enforcement to ensure compliance |
| • Has a protocol for monitoring staff compliance with infection prevention procedures, including PPE use, hand hygiene, isolation, and others |
| • Has protocols for environmental decontamination during an MCE, including cleaning patient rooms, managing “white powder” or other environmental contamination incidents, cleaning/disinfection/sterilization of patient care items, reprocessing of equipment when resources are limited, cleaning/decontaminating patients' valuables and belongings when necessary, and cleaning and inspecting environment before reopening a previously closed area of the hospital |
| • Defines a procedure for conducting and coordinating the epidemiologic outbreak investigation of a biologic event with the local health department and identifies a person (and back-up person) at the hospital who will be the leader/coordinator of the investigation at the hospital |
| • Has a protocol for implementing an on-site quarantine that is coordinated with local public health officials, including plans for ensuring compliance and providing necessary supplies to maintain the quarantine |
| • Has a protocol for coordinating with security or local law enforcement entities to enforce isolation and quarantine orders on-site |
| • Has a protocol for managing animals or pets in the hospital, including care/management of staffs' pets if employees are confined to work for extended periods of time during an MCE |
| • Has prioritization plans/algorithms for allocating limited PPE, hand hygiene products, ventilators, anti-infective therapy or vaccination, and other supplies/products that affect infection transmission during a biologic event |
| • Describes how the hospital Ethics Committee is involved in the development of crisis standards of care for the facility |
| Infection prevention policies and procedures related to patient management |
| • Has a protocol for identifying when and how to perform patient decontamination related to a biologic event (ie, an overt bioterrorism attack) |
| • Has a protocol for internal and external patient transport of potentially contagious patients, including coordination with local emergency medical services and 9-1-1 services for interfacility transfer |
| • Has a protocol for determining patient placement of potentially contagious patients, including plans for cohorting of patients with known or suspected communicable diseases during a biologic event |
| • Has a protocol for designating staff limited to work with potentially infected patients (ie, staff cohorting) |
| • Has a protocol for instituting Standard and Transmission-Based Precautions for all biologic events (bioterrorism, outbreaks of emerging infectious diseases, and pandemics), including procedures for implementing respiratory hygiene practices2-5.7.9.14.19.24-28.35.37.38.39.42-43,49 |
| • Has a procedure for identifying and managing vulnerable individuals/groups who may be at an increased risk of infection during a biologic event |
| • Has an inventory or list of all available isolation rooms/areas, including AIIRs and negative-pressure rooms/areas |
| • Has a protocol for assessing the functionality of all AIIRs before patient admittance for isolation |
| • Has a protocol for handling, transporting, and laundering soiled linens, including times when routine linen cleaning/washing cannot occur because of the MCE |
| • Has a protocol for patient discharge (where they will be discharged to, decision matrix for deciding/prioritizing who is discharged, discharge instructions to reduce the risk of disease spread, and others) specific to biologic events |
| • Has a protocol for postmortem care procedures that limit infection transmission during a biologic event |
| Occupational health policies and procedures |
| • Has a program that offers and monitors compliance with the annual influenza vaccine for hospital employees |
| • Has a respiratory protection program that fit-tests staff for respirators or provides and trains staff on the use of PAPRs that do not require fit-testing |
| • Has a liberal/nonpunitive sick leave policy that addresses the needs of ill and symptomatic personnel during a biologic event, including allowances and encouragement for sick employees to stay home until no longer contagious or furloughing exposed or infected staff |
| • Has a protocol for managing personnel who become ill during a biologic event, including what to do when staff develop symptoms while at work and outlining how long staff must remain off-duty after becoming infected |
| • Has a protocol for identifying and managing staff who are at an increased risk for infection during a biologic event (eg, pregnant women, immunocompromised workers, and employees of age 65 years or older), such as administrative leave, furlough, altering work assignment or location, and others |
| • Has a protocol for tracking staff who have had contact with a potentially contagious patient or contaminated source (ie, an exposure) during a biologic event, including offering PEP when indicated |
| • Has a protocol for tracking staff who have recovered from illness during a biologic event, including confirmed and probable cases |
| • Has a protocol that addresses if, how, and when long-term prophylaxis for employees will be provided during a pandemic and to which staff this policy applies |
| • Has a protocol for notifying staff's other employers if the staff are exposed or infected during a biologic event |
| • Includes a policy for the prevention of occupational injury and exposure to bloodborne pathogens during an MCE, including times when PPE or other resources are limited |
| Surveillance and triage |
| • Identifies a process for syndromic surveillance to identify or detect a biologic event, including bioterrorism, outbreaks of emerging infectious diseases, and pandemic influenza; collection indicators (chief complaint, hospital admissions, unusual clusters of pneumonia, rashes, flu-like illness, and others, are identified in plan) |
| • Outlines the hospital's participation in a community-wide syndromic surveillance program to identify or detect a biologic event; collection indicators (chief complaint, hospital admissions, and others) are identified in plan |
| • Defines the frequency with which syndromic surveillance reports/data will be sent to infection prevention/hospital epidemiology and local public health agency; frequency of data sharing reflects the pandemic security level |
| • Identifies a process for surveillance to monitor for potentially contagious diseases during a MCE after it is identified, including screening of patients, visitors, and staff; frequency of surveillance (upon admittance to hospital, before each shift, and others) is identified |
| • Has a protocol for surveillance based on the level of disease in the community (such as preevent passive surveillance using signage and midevent active surveillance using temperature/symptom screening for hospital visitors) |
| • Identifies a process for testing and evaluating the syndromic surveillance program/system being used to detect pandemic influenza (the program/system is evaluated during the seasonal influenza period) |
| • Includes a protocol for tracking admissions and discharges of patients with potentially communicable diseases during a MCE |
| • Has a protocol for tracking all onsite individuals (patients, visitors, and staff) who have had contact with a potentially infectious patient during a MCE |
| • Identifies a protocol for monitoring staff absenteeism for health reasons |
| • Describes a written protocol for monitoring and reporting seasonal influenza-like illness among hospitalized patients, volunteers, and staff |
| • Has a procedure for identifying, monitoring, and tracking health care-associated infection transmission among hospitalized patients, volunteers, and staff, including nosocomial transmission of SARS |
| • Identifies a process for monitoring individuals who are quarantined on-site for signs/symptoms of contagious diseases |
| • Includes plans for a designated location that is physically separated from other triage/evaluation areas for triaging patients with possible communicable diseases during a biologic event |
| • Has a protocol for creating or has triage signage that addresses language barriers, individuals with disabilities (visual, hearing, or others), and varying reading levels |
| Reporting, communication plan, and information management |
| • Includes a protocol for 24/7 notification of infection prevention or hospital epidemiology of a known or suspected biologic event, including bioterrorism, outbreaks of emerging infectious diseases, and pandemics |
| • Includes a protocol for notifying local health officials and local law enforcement of a known or suspected biologic event, including bioterrorism, outbreaks of emerging infectious diseases, and pandemics |
| • Identifies the name, title, and contact information of a primary and back-up person assigned to communicate with hospital staff and volunteers regarding activation of the Plan and the status and impact of the biologic event during the incident |
| • Identifies the name, title, and contact information of a primary and back-up person assigned to communicate with public health authorities during a biologic event |
| • Identifies a person assigned to monitor state and federal public health advisories and update the pandemic response coordinator and members of the hospital emergency management committee when pandemic flu has been reported in the United States and is nearing the geographic area |
| • Includes a list and contact information of other health care entities and key community response entities (fire safety, law enforcement, EMS, public health, and governmental agencies) within the region with which it will be necessary to maintain real-time communication during a biologic event |
| • Describes the process with which health alert messages, information about contagious diseases, hospital rules for visitors, and need for and use of infection control measures (social distancing practices, isolation, PPE, and others) will be posted and/or communicated within the facility during an MCE (such as through an intranet, hotline, closed-circuit TV, and others) |
| • Describes the process with which the hospital has arranged mechanisms and content for interfacility communication with other hospitals and health care agencies in the region for safe patient placement during a biologic event, including during admission and discharge procedures (includes information on PPE, isolation, and other infection prevention interventions) |
| • Describes the process with which the hospital has shared estimates regarding the quantities of essential patient care materials/equipment and PPE with local, regional, state, and tribal planning groups to better plan stockpiling agreements |
| • Describes procedures for obtaining and communicating infection prevention information when phone lines are not available |
| • Includes preevent messages and materials about the most likely biologic agents to be involved in an MCE that can be communicated to staff, visitors, patients, and the general public during an MCE |
| Laboratory infection prevention issues |
| • Has a process for obtaining laboratory services 24/7 |
| • Has a procedure for collecting, labeling, packaging, processing, and transporting laboratory specimens believed to be potential bioterrorism agents or emerging infectious diseases, including protocols for internal and external transport |
| • Has a procedure for coordinating the processing of laboratory specimens with regional laboratories, including the LRN |
| • Has a process for evaluating and tracking 100% of all microbiology results and stratifying the report according to organism |
| • Has a procedure for collecting and managing evidence during a known or suspected bioterrorism event, including coordination with local law enforcement and chain of custody documentation |
| Surge capacity issues |
| • Has a plan for surge capacity to handle an influx of potentially contagious patients |
| • Estimates the quantities of essential patient care materials/equipment and PPE that would be needed for an 8-week period (ie, the estimated wave of a pandemic). Examples of patient care materials/equipment and PPE: intravenous pumps, ventilators, anti-infective therapy, vaccination, diagnostic testing materials, linens, respiratory protection, gowns, gloves, eye protection, hand hygiene products, and others |
| • Estimates the current staff shortages and staffing levels during an MCE |
| • Has a protocol for assessing and finding/supplying essential patient care materials/equipment and PPE stocks during an MCE |
| • Includes protocols for health care worker surge capacity that acknowledges that staff may be less willing or able to work during a biologic event (because of health care worker illness or quarantine, family obligations, or fear leading to reluctance or refusal to work) and that more staff will be needed because of worker fatigue from wearing PPE for extended periods of time and has contingency plans for these types of situations |
| • Includes a protocol for interim and/or long-term negative-pressure surge capacity (ie, AIIRs, negative-pressure rooms/areas, or other protective environments) |
| • Estimates the current quantities of linens for patient care and has a plan to obtain additional linen during an MCE |
| • Estimates the current hospital laboratory capacity and surge capacity potential, including an inventory of laboratory supplies |
| • Identifies current morgue capacity and has protocol for obtaining morgue surge capacity to limit infection transmission during a biologic event |
| • Includes a protocol for maximizing staff's ability and willingness to work during an MCE, such as offering worker incentives and encouraging staff to have a personal disaster plan |
| Anti-infective therapy, chemoprophylaxis, and vaccination |
| • Estimates the current quantities of anti-infective therapy, chemoprophylaxis, and vaccines on-hand |
| • Includes a protocol for establishing and/or maintaining a medication and vaccine stockpile and/or coordination plans with regional health care facilities or vendors to obtain additional anti-infective therapy supplies during an MCE |
| • Includes a prioritization plan for staff and their family members regarding who would be the first priority for anti-infective therapy, chemoprophylaxis, and vaccine during times of limited resources |
| • Has a protocol for identifying the most current recommendations and guidance on the use of anti-infective therapy and chemoprophylaxis needed for a biologic event |
| • Has a protocol for expediting administration of anti-infective therapy, chemoprophylaxis, or vaccine to patients, staff, and/or staff's family as recommended by public health officials |
| • Defines the role, if any, of the facility in a large scale program to distribute anti-infective therapy, chemoprophylaxis, or vaccine to the general population, including hospital visitors and the general public |
| • Includes a protocol for performing follow-up monitoring and treatment of staff, patients, and/or visitors who received anti-infective therapy, chemoprophylaxis, or vaccine |
| • Includes security procedures as needed for control and administration of anti-infective therapy, chemoprophylaxis, or vaccine during MCEs |
| Infection prevention education |
| • Has a designated person who creates, coordinates, and tracks standardized staff training on biologic threats and emergency management |
| • Has a protocol that outlines the types of information that will be provided to staff related to biologic threats and emergency management, the frequency this training will take place, and how competence will be assessed |
| • Has a protocol that outlines the types of information that will be provided to patients, visitors, and the general public; who will provide this training; and when and how this education will be provided |
| • Includes agent-specific information (such as background on the agent/disease, epidemiology of the agent/disease, clinical features, incubation period, case definition, staff educational materials, quick reference materials for staff, and educational materials for patients and visitors) for the most likely agents to be used in a bioterrorism attack or those that might occur during an outbreak of an emerging infectious disease or pandemic (SARS, avian influenza, or others) |
| • Includes disease-specific patient management information (such as criteria for detecting a possible case, screening form for the disease, diagnostic workup to be performed when ruling out the disease, medical treatment, vaccination, postexposure follow-up or treatment, patient placement, route of transmission, isolation precautions and PPE needed, environmental decontamination procedures, and home care or discharge instructions) |
| Physical plant infection prevention issues |
| • Has a protocol for food safety practices, including holding temperatures and times to prevent foodborne illness during MCEs when standard utilities may not be available |
| • Has a procedure for handling/managing increases in regular and regulated medical waste during MCEs, including times when regular waste management pick-up is not possible because of the event |
| • Has protocol for assessing for functioning sewer after an MCE |
| • Has protocol for assessing for water, dust, or other contaminate infiltration after an MCE |
| • Has procedure for obtaining additional functional or chemical toilets after an MCE |
| • Has procedure for obtaining additional water during an MCE for sanitation and hand hygiene needs |
AIIR, airborne infection isolation room; EMS, emergency medical services; LRN, laboratory response network; MCE, mass casualty event; PAPR, powered air purifying respirator; PEP, postexposure prophylaxis; PPE, personal protective equipment.
Topics for staff education related to infection prevention during emergency management
| Education topics |
| • Self-screening for illness |
| • Screening/triaging of patients for communicable diseases/conditions |
| • Internal and external reporting and communication procedures |
| • Surveillance during mass casualty events |
| • Plan policies and procedures related to infection prevention |
| • Disease transmission methods/routes |
| • Isolation procedures |
| • Respiratory hygiene |
| • PPE use and reuse, including use of respiratory protection |
| • Hand hygiene protocols |
| • Social distancing |
| • Handling contaminated linens |
| • Obtaining and handling patient specimens safely |
| • Environmental cleaning/disinfection |
| • Disinfection and sterilization of medical equipment |
| • Waste management procedures |
| • Patient decontamination procedures |
| • Medical management of biologic event victims, including identification and diagnosis of disease, and clinical care procedures (treatment, isolation, and others) |
| • Postmortem care |
| • Influenza vaccine |
| • Impact of influenza |
PPE, personal protective equipment.